Extra value from Tocris Bioscience
Tocris is pleased to provide the following promotional offer(s):
To be kept up to date with the latest new products and special offers from Tocris, please sign-up for new product e-alerts.
Find multiple products by catalog number
Potent, selective LRRK2 inhibitor
Tocris is the first to launch GSK2578215A, licensed from GlaxoSmithKline, for the study of Parkinson's Disease.